Connect with us

Crypto

Ripple Announces First Commercial Customers for XRP in France and Sweden

A spokesperson for Lemonway said that Ripple ODL is expected to increase efficiency and independence from traditional banks. Xbaht, on the other hand, was founded in Sweden back in 2016 and focuses on organizing remittances from Thais to their home country. Using Ripple ODL in Sweden will also involve Tranglo, a leading Asian financial services provider.

Published

on

Despite the lawsuit between the U.S. Securities and Exchange Commission and Ripple over XRP, the crypto company is trying to expand its business, at least outside the United States. Ripple ODL (On Demand Liquidity) plays a central role in this, as this program allows banks and financial service providers to use XRP as a bridge currency without having to hold much liquidity themselves. That is to show XRP’s advantages in international transfers, namely high speed with low fees. With the financial service providers Lemonway from France and Xbaht from Sweden, Ripple now announced two new partners via a press release, which want to use ODL and should be the first in their countries.

According to the press release, Lemonway, headquartered in Paris, specializes in processing payments on online platforms and already has 8 million customers throughout Europe. A spokesperson for Lemonway said that Ripple ODL is expected to increase efficiency and independence from traditional banks. Xbaht, on the other hand, was founded in Sweden back in 2016 and focuses on organizing remittances from Thais to their home country. Using Ripple ODL in Sweden will also involve Tranglo, a leading Asian financial services provider that has already been using XRP as a bridge currency on a large scale since March.

The debut collaborations in Sweden and France are the first taste of success for Ripple’s new European head, Sendi Young. Young took up her post in the summer and she had already emphasized the great importance of Europe for Ripple ODL at that time. Quarterly reports show: Billions are being moved via XRP and Ripple ODL, and the business sector is growing rapidly.

Read more about Ripple’s new partnerships in France and Sweden and find other interesting business headlines with the Born2Invest mobile app.

Ripple CEO Garlinghouse: ‘answers’ to SEC lawsuit expected in H1 2023

Meanwhile, according to Bloomberg, Ripple CEO Brad Garlinghouse commented at a conference on the situation in the ongoing case against the SEC. He said he expects “answers” in the lawsuit in the 1st half of 2023, but would not commit to a quarter. Although Ripple and the SEC have most recently requested a verdict in the written proceedings, ever new legal maneuvers make a quick end unlikely. In that respect, a second comment from Garlinghouse is interesting. For he said Ripple could envision an out-of-court settlement with the SEC if the agency was willing to stop pursuing XRP as a “security.” This classification is more than symbolic for the crypto industry, as it is feared: If the SEC can prevail against Ripple and XRP, the regulator will also target other altcoins.

Bottom line: are the SEC and Ripple converging for comparison to XRP?

When Ripple and the SEC submitted their motions for adjudication nearly a month ago, observers had already noticed that the SEC was moving away from the term “securities” for XRP in its choice of words. If one now takes the latest statements of Garlinghouse into account, this may also be a hidden offer to finally bring the mammoth process to an end through a settlement. Because even if the expansion towards Europe with Ripple ODL is to be evaluated positively – without institutional use of XRP in the USA, the payment corridors of Ripple remain incomplete at an important point. Here, only a court ruling or a settlement between Ripple and the SEC can convince US companies again to give XRP a chance as a bridge currency.

__

(Featured image by WorldSpectrum via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in BLOCK-BUILDERS.DE, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Helene Lindbergh is a published author with books about entrepreneurship and investing for dummies. An advocate for financial literacy, she is also a sought-after keynote speaker for female empowerment. Her special focus is on small, independent businesses who eventually achieve financial independence. Helene is currently working on two projects—a bio compilation of women braving the world of banking, finance, crypto, tech, and AI, as well as a paper on gendered contributions in the rapidly growing healthcare market, specifically medicinal cannabis.